System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ppublish 1 citation

PubMed: 42471109 DOI: 10.1016/j.bcp.2026.118264

Modulation of the gut microbiota by Lacticaseibacillus paracasei reduces adipogenesis and metabolic dysregulation in high-fat diet-induced obese mice.

Biochem Pharmacol 253(Pt 1):118264

Authors: Jose Alberto Molina-Tijeras, Laura Hidalgo-García, Laura López-Escanez, Teresa Vezza, Patricia Diez-Echave, Jorge García-García, Antonio Jesús Ruiz-Malagón, María Jesús Rodríguez-Sojo, Miguel Romero, Iñaki Robles-Vera, Federico García, Julio Plaza-Diaz, Óscar Bañuelos, Mónica Olivares, Juan Duarte, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Julio Gálvez

Affiliations

  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Department of Health, Medicine and Life Sciences, Faculty of Science, Technology and Medicine, University of Luxembourg, 4367-Esch-sur-Alzette, Luxembourg.
  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Digestivo, Hospital Universitario Virgen de las Nieves, 18012 Granada, Spain.
  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain; CIBER de Enfermedades Infecciosas (CIBER-INFECC), Instituto de Salud Carlos III, Madrid, Spain.
  • ANUT-DSM (Alimentaciò, Nutrició Desenvolupament i Salut Mental), Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, 43201 Reus, Spain; School of Health Sciences, Universidad Internacional de la Rioja, 26001 Logroño, Spain.
  • Kerry Group, 18004 Granada, Spain.
  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; CIBER-Enfermedades Cardiovasculares (CIBER-ECV), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; CIBER-Enfermedades Hepáticas y Digestivas (CIBER-EHD), Instituto de Salud Carlos III, Madrid, Spain.

Abstract

The rising interest in microbiota-based therapies has positioned probiotics as promising candidates for managing obesity. This study evaluated the effects of Lacticaseibacillus paracasei in a murine model of high-fat diet (HFD)-induced obesity. Oral administration of L. paracasei significantly reduced body weight gain and adiposity without altering food intake, indicating improved energy efficiency. Probiotic supplementation enhanced insulin sensitivity and glucose tolerance, as shown by lower fasting glucose, insulin levels, and HOMA-IR. At the molecular level, L. paracasei downregulated adipogenic genes (Srebf1, Pparg, Cebpa, Fabp4) and upregulated Ucp-1, suggesting increased browning of white adipose tissue. Inflammatory markers (Tnf-α, Il-6, Mcp-1) and JNK pathway activation were decreased, while insulin signaling and lipid metabolism improved via increased Glut4 and Pparα, and modulation of adipokines. In the liver, the probiotic attenuated steatosis, reduced oxidative stress, and modulated genes related to lipid metabolism. Gut barrier integrity was improved, as indicated by higher expression of tight junction proteins, lower LPS levels, and reduced Tlr4 expression. L. paracasei also reshaped the gut microbiota, decreasing the Bacillota/Bacteroidota ratio and increasing beneficial taxa such as Akkermansia muciniphila and Lactobacillus, while reducing Clostridium spp. Additionally, it normalized obesity-associated miRNAs involved in adipogenesis and inflammation. Finally, the probiotic improved endothelial function and reduced vascular oxidative stress. These results support L. paracasei as a promising probiotic for obesity management, acting through metabolic, inflammatory, and microbiota-mediated mechanisms.

MeSH

Genes, Adipogenesis, Insulin, Biochemistry, Stress, Physiological, Oxidative Stress, Diet, High-Fat, Diet, Probiotics, Obesity, Gastrointestinal Microbiome, Microbiota